Azienda Ospedaliera Universitaria Luigi Vanvitelli

Naples 80131

3 studies enrolling now · 6 studies all time

What they study most

Atopic Dermatitis, Brain Metastases From HER2 and Breast Cancer, Brain Metastases From Solid Tumors, CNS Metastases, Cholangiocarcinoma, Esophageal Squamous Cell Carcinoma, HER2, HER2 + Breast Cancer, HER2 + Gastric Cancer, HER2 Mutation-Related Tumors, HER2-Positive Solid Tumors, HER2-positive Bladder Cancer

Studies at this site

• A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01) — Recruiting now
• A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis — Recruiting now
• A Phase 1/1b Study of IAM1363 in HER2 Cancers — Recruiting now
• A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) — Stopped early
• Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma — Running, not enrolling
• A Study to Evaluate Rocatinlimab (AMG 451) in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) — Completed